Published in Clin J Am Soc Nephrol on September 10, 2008
Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in Taiwan. BMC Nephrol (2013) 0.81
Cum hoc, ergo propter hoc: health disparities real and imagined. Clin J Am Soc Nephrol (2009) 0.75
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2007) 5.26
Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest (1985) 2.72
Hemoglobin levels according to age, race, and transferrin saturation in preschool children of comparable socioeconomic status. J Pediatr (1973) 2.64
Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med (2006) 2.58
Racial differences in mortality among those with CKD. J Am Soc Nephrol (2008) 2.53
Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr (1992) 2.53
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32
Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab (2000) 2.28
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26
Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr (1994) 2.26
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) (2006) 1.50
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol (2007) 1.50
Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women. J Bone Miner Res (1994) 1.42
A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol (2004) 1.37
Risk for osteoporosis in black women. Calcif Tissue Int (1996) 1.32
The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women. Am J Epidemiol (1991) 1.29
Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract (2007) 1.26
The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol (2002) 1.25
Racial differences in urinary potassium excretion. J Am Soc Nephrol (2008) 1.18
Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol (2007) 1.17
Relation between ingested potassium and sodium balance in young Blacks and whites. Am J Clin Nutr (1983) 1.10
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int (2003) 1.10
Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab (1999) 1.09
On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis (1998) 0.97
Aging and bone metabolism in African American and Caucasian women. J Clin Endocrinol Metab (1996) 0.97
Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab (1995) 0.95
Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase. J Clin Invest (1985) 0.94
Creatinine clearance, electrolytes, and plasma renin activity related to the blood pressure of white and black children--the Bogalusa Heart Study. J Lab Clin Med (1979) 0.93
Factors related to parathyroid weight in normal persons. Arch Pathol Lab Med (1983) 0.92
Racial differences in potassium disposal. Kidney Int (2004) 0.88
Potassium intake and cardiovascular reactivity in children with risk factors for essential hypertension. J Pediatr (1997) 0.82
A preliminary report of vitamin D and calcium metabolism in older African Americans. J Am Geriatr Soc (1993) 0.80
Metabolic bone disease in the elderly. Biochemical studies in three different racial groups living in South Africa. S Afr Med J (1975) 0.78
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol (2008) 6.91
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med (2011) 4.62
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol (2006) 3.51
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int (2009) 3.32
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol (2005) 2.79
End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol (2007) 2.73
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int (2004) 2.63
CKD: common, harmful, and treatable--World Kidney Day 2007. Am J Kidney Dis (2007) 2.58
Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med (2003) 2.54
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol (2005) 2.51
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int (2005) 2.45
KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 2.43
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol (2009) 2.41
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. Am J Kidney Dis (2005) 2.36
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int (2002) 2.36
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis (2003) 2.30
Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med (2008) 2.26
The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant (2005) 2.24
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. Kidney Int (2011) 2.10
A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis (2005) 2.09
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol (2010) 2.08
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol (2005) 2.06
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol (2012) 2.03
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol (2006) 2.01
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc (2005) 1.96
Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation (2002) 1.91
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res (2007) 1.88
Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery. Ann Thorac Surg (2011) 1.85
Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis (2005) 1.84
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
Hydrogen-treated TiO2 nanowire arrays for photoelectrochemical water splitting. Nano Lett (2011) 1.71
A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int (2002) 1.71
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70
Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol (2006) 1.70
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Body mass index and mortality in CKD. Am J Kidney Dis (2007) 1.68
A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis (2002) 1.65
End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol (2005) 1.65
Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol (2007) 1.64
Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation (2002) 1.63
Towards case-mix-adjusted international renal registry comparisons: how can we improve data collection practice? Nephrol Dial Transplant (2009) 1.62
Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol (2007) 1.61
Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int (2004) 1.61
Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol (2007) 1.58